ImmunityBio
ImmunityBio pioneers innovative therapies to conquer disease through immune system reprogramming. Learn more
Launch date
Employees
Market cap
€2.5b
Enterprise valuation
€2.9b (Public information from Sep 2024)
Share price
$3.9 IBRX
Culver City California (HQ)
Authorizing premium user...